AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsyfor Mesial Temporal Lobe Epilepsy18 locations incl. BirminghamSponsor: UniQure Biopharma B.V.Sex: All·Age: 18 - 75Code: NCT06063850·Phase 1, Phase 2·RecruitingApply to this trial
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infectionsfor Neutropenia22 locations incl. PhoenixSponsor: X4 PharmaceuticalsSex: All·Age: 12+Code: NCT06056297·Phase 3·RecruitingApply to this trial
Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosisfor Light Chain (AL) Amyloidosis18 locations incl. BerkeleySponsor: Nexcella Inc.Sex: All·Age: 18 - 120Code: NCT06097832·Phase 1, Phase 2·RecruitingApply to this trial
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinibfor MyelofibrosisDrug: Ruxolitinib58 locations incl. BirminghamSponsor: Kartos Therapeutics, Inc.Sex: All·Age: 18+Code: NCT06479135·Phase 3·RecruitingApply to this trial
Multi-Center Clean Air Randomized Controlled Trial in COPDfor Chronic Obstructive Pulmonary Disease (COPD)11 locations incl. BirminghamSponsor: JHSPH Center for Clinical TrialsSex: All·Age: 40+Code: NCT06376994·Phase 3·RecruitingApply to this trial
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancerfor Non-small Cell Lung Cancer22 locations incl. BirminghamSponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)Sex: All·Age: 18+Code: NCT06343402·Phase 1·RecruitingApply to this trial
Evaluation of Outcomes of the Triathlon Hinge Knee (THK) Systemfor Knee Arthropathy2 locations incl. WestonSponsor: The Cleveland ClinicSex: All·Age: All agesCode: NCT06379321·RecruitingApply to this trial
Preventing Injured Knees From osteoArthritis: Severity Outcomesfor Osteoarthritis, Knee9 locations incl. AtlantaSponsor: Brigham and Women's HospitalSex: All·Age: 18 - 45Code: NCT06096259·Phase 2·RecruitingApply to this trial
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilastfor Idiopathic Pulmonary FibrosisDrug: Nerandomilast58 locations incl. BirminghamSponsor: Boehringer IngelheimSex: All·Age: 18+Code: NCT06238622·Phase 3·RecruitingApply to this trial
Engaging Patients in Prenatal Genetic Testing Decisions as a Pathway to Improve Obstetric Outcomesfor Prenatal Disorder3 locations incl. ClevelandSponsor: The Cleveland ClinicSex: Female·Age: 18 - 50Code: NCT06382636·RecruitingApply to this trial
Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumabfor Advanced Solid Tumor6 locations incl. ScottsdaleSponsor: Strand Therapeutics Inc.Sex: All·Age: 18+Code: NCT06249048·Phase 1, Phase 2·RecruitingApply to this trial
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinomafor Renal Cell Carcinoma20 locations incl. TucsonSponsor: HiberCell, Inc.Sex: All·Age: 18+Code: NCT06234605·Phase 1·RecruitingApply to this trial
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopeniafor MyelofibrosisDrug: Selinexor7 locations incl. DuarteSponsor: Karyopharm Therapeutics IncSex: All·Age: 18+Code: NCT05980806·Phase 2·RecruitingApply to this trial
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancerfor Squamous Cell Carcinoma of Head and NeckDrug: Amivantamab15 locations incl. La JollaSponsor: Janssen Research & Development, LLCSex: All·Age: 18+Code: NCT06385080·Phase 1, Phase 2·RecruitingApply to this trial
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungsfor Lung Cancer, Non-small Cell14 locations incl. DothanSponsor: Krystal Biotech, Inc.Sex: All·Age: 18+Code: NCT06228326·Phase 1, Phase 2·RecruitingApply to this trial
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesionsfor In-Stent Restenosis28 locations incl. BirminghamSponsor: Concept Medical Inc.Sex: All·Age: 18 - 110Code: NCT05908331·RecruitingApply to this trial
Platform Clinical Study for Conquering Sclerodermafor Interstitial Lung Disease Due to Systemic Disease34 locations incl. BirminghamSponsor: Scleroderma Research Foundation, Inc.Sex: All·Age: 18+Code: NCT06195072·Phase 2·RecruitingApply to this trial
A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosisfor Pulmonary Fibrosis59 locations incl. BirminghamSponsor: Avalyn Pharma Inc.Sex: All·Age: 18+Code: NCT06329401·Phase 2·RecruitingApply to this trial
A Cognitive Risk Calculator and Screening Tool for Primary Care Settingsfor Cognitive Risk Assessment1 location in ClevelandSponsor: The Cleveland ClinicSex: All·Age: All ages·Accepts healthy volunteersCode: NCT06506877·Enrolling By Invitation
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate Cancerfor Prostate Cancer44 locations incl. HomewoodSponsor: Curium US LLCSex: Male·Age: 18+Code: NCT06235151·Phase 3·RecruitingApply to this trial
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVCfor Arrhythmogenic Right Ventricular Cardiomyopathy7 locations incl. San FranciscoSponsor: Tenaya TherapeuticsSex: All·Age: 18 - 65Code: NCT06228924·Phase 1·RecruitingApply to this trial
A Phase 1/1b Study of IAM1363 in HER2 Cancersfor HER2 Mutation-Related Tumors29 locations incl. La JollaSponsor: Iambic Therapeutics, IncSex: All·Age: 18+Code: NCT06253871·Phase 1·RecruitingApply to this trial
Functional Brain Network Changes in Patients Undergoing Deep Brain Stimulation for Essential Tremorfor Essential Tremor1 location in ClevelandSponsor: The Cleveland ClinicSex: All·Age: 30 - 80·Accepts healthy volunteersCode: NCT06293638·RecruitingApply to this trial
Maintenance Obinutuzumab in Treating Patients With Central Nervous System Lymphoma Who Have Achieved a Complete or Partial Responsefor Primary Central Nervous System Lymphoma7 locations incl. New YorkSponsor: Providence Health & ServicesSex: All·Age: 18+Code: NCT06175000·Phase 2·RecruitingApply to this trial
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancerfor Stage III Ovarian CancerDrug: Niraparib59 locations incl. DuarteSponsor: GOG FoundationSex: Female·Age: 18+Code: NCT05659381·Phase 3·RecruitingApply to this trial
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancerfor Small Cell Lung Cancer30 locations incl. DaphneSponsor: Puma Biotechnology, Inc.Sex: All·Age: 18+Code: NCT06095505·Phase 2·RecruitingApply to this trial
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)for Multiple MyelomaDrug: Elranatamab97 locations incl. MobileSponsor: PfizerSex: All·Age: 18+Code: NCT06152575·Phase 3·RecruitingApply to this trial
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomidefor Multiple MyelomaDrug: Talquetamab49 locations incl. ClovisSponsor: Janssen Research & Development, LLCSex: All·Age: 18+Code: NCT06208150·Phase 3·RecruitingApply to this trial
Effect of Limb Length Ratio on Roux-en-Y Gastric Bypass Outcomes (CLIMB II Study)for Morbid Obesity1 location in ClevelandSponsor: Salvador NavarreteSex: All·Age: 18 - 70Code: NCT06293703·RecruitingApply to this trial
Early Diagnosis of Pancreatic Cancer Duodenal Fluid-Based Biomarker Exploratory Studyfor Pancreatic Cancers2 locations incl. AuroraSponsor: Do Hyun ParkSex: All·Age: 19+·Accepts healthy volunteersCode: NCT07030348·RecruitingApply to this trial
A Phase I/II, Open-label Study to Investigate the Safety, Tolerability, PK, and Preliminary Efficacy of FB849for Advanced Solid Tumor5 locations incl. ClevelandSponsor: 1ST Biotherapeutics, Inc.Sex: All·Age: 18+Code: NCT05761223·Phase 1, Phase 2·RecruitingApply to this trial
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)for Transthyretin Amyloidosis (ATTR) With Cardiomyopathy38 locations incl. TucsonSponsor: Intellia TherapeuticsSex: All·Age: 18 - 90Code: NCT06128629·Phase 3·RecruitingApply to this trial
Spartan Stem, World Cup and World Liner Post Market Clinical Follow-up Studyfor Hip Replacement1 location in ClevelandSponsor: Signature OrthopaedicsSex: All·Age: 18 - 75Code: NCT06172569·RecruitingApply to this trial
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United Statesfor Cirrhosis13 locations incl. La JollaSponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Sex: All·Age: 18 - 75Code: NCT05832229·Phase 2·RecruitingApply to this trial
Readiness Brain Operation Optimization Training (ReBOOT) for Epilepsy Surgeryfor Epilepsy1 location in ClevelandSponsor: Kayela ArrottaSex: All·Age: 18 - 60Code: NCT05992402·RecruitingApply to this trial
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.for Breast Cancer79 locations incl. PhoenixSponsor: BriaCell Therapeutics CorporationSex: All·Age: 18+Code: NCT06072612·Phase 3·RecruitingApply to this trial
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasmsfor Myeloproliferative NeoplasmsDrug: Ruxolitinib13 locations incl. DuarteSponsor: Incyte CorporationSex: All·Age: 18+Code: NCT06034002·Phase 1·RecruitingApply to this trial
The Fourth Left Atrial Appendage Occlusion Studyfor Atrial Fibrillation51 locations incl. BirminghamSponsor: Hamilton Health Sciences CorporationSex: All·Age: 18+Code: NCT05963698·RecruitingApply to this trial
Safety and Efficacy of the VERTICA® RF Device for the Treatment of EDfor Erectile Dysfunction7 locations incl. Newport BeachSponsor: OHH-MED Medical LtdSex: Male·Age: 22 - 85·Accepts healthy volunteersCode: NCT06167733·RecruitingApply to this trial
Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostatefor Benign Prostatic Hyperplasia With Outflow Obstruction1 location in ClevelandSponsor: The Cleveland ClinicSex: Male·Age: 18+Code: NCT06179654·RecruitingApply to this trial